Table 3-.

Secondary outcomes associated with the Medication Assisted Treatment (MAT) Program.

	Medication Assisted Treatment (MAT) Program Participants
	B-MAT† cohort: Enrolled >=90 Days				E-MAT* cohort: Enrolled >=365 Days
	n=288				n=221
Patients	Day 0	@ Day 30	@ Day 60	@ Day 90	Day 0	@ Day 90	@ Day 180	@ Day 270	@ Day 365
Enrolled and attending MAT (in treatment)	288	284	279	271	221	213	188	154	127
Successfully Discharged	0	0	0	0	0	0	3	12	20
Unsuccessfully Discharged	0	1	5	12	0	7	25	48	65
Transferred	0	2	3	4	0	0	4	6	8
Died	0	1	1	1	0	1	1	1	1
Total Patients	288	288	288	288	221	221	221	221	221
Urine Analysis (UA)	Day 0	Day 1–30	Day 31–60	Day 61–90	Day 0	Day 1–90	Day 91–180	Day 181–270	Day 271–365
# of Patients	288	193	182	177	221	176	151	132	100
# of Tests	290	574	530	482	222	1159	894	738	625
# of Negative tests: opioid substances	0	414	410	363	0	862	708	588	523
# of Negative tests: All illegal substances	0	306	312	283	0	645	526	438	388
Measures
Median Tests per Patient	1	3	4	4	1	8	8	7.5	8
Percentage patients with at least 1 UA test	100%	68%	65%	65%	100%	83%	80%	86%	79%
% Negative UA tests for opioid substances	NA	72%	77%	75%	NA	74%	79%	80%	84%
% Negative UA tests for all illegal substances	NA	53%	59%	59%	NA	56%	59%	59%	62%
Count of successful discharges	0	0	0	0	0	0	3	9	8
Count of unsuccessful discharges	0	1	4	7	0	7	18	23	17

^†B-MAT: Brief Medication Assisted Treatment cohort included individuals with at least 90 days of enrollment

^*E-MAT: Extended Medication Assisted Treatment cohort included individuals with at least 365 days of enrollment. All participants in the E-MAT cohort were also reported in the B-MAT cohort